TRAVERE THERAPEUTICS, INC. (TVTX) Net margin 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) net profit margin by fiscal year — reported net income divided by reported revenue.
-5.2%FY2025 · since FY2016: -35.9% → -5.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.2% | +132.7 pp |
| FY2024 | -137.9% | -61.2 pp |
| FY2023 | -76.7% | +177.7 pp |
| FY2022 | -254.4% | -117.8 pp |
| FY2021 | -136.6% | -51.2 pp |
| FY2020 | -85.4% | -1.9 pp |
| FY2019 | -83.5% | -21.0 pp |
| FY2018 | -62.5% | -24.0 pp |
| FY2017 | -38.6% | -2.7 pp |
| FY2016 | -35.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice